{
    "root": "35420d8c-7a05-0220-e063-6394a90a1c25",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nebivolol",
    "value": "20250516",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "NEBIVOLOL HYDROCHLORIDE",
            "code": "JGS34J7L9I"
        },
        {
            "name": "D&C RED NO. 27",
            "code": "2LRS185U6K"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        }
    ],
    "indications": "nebivolol beta-adrenergic blocking agent indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 )",
    "contraindications": "taken without food . individualize needs patient monitor up-titration . ( 2 ) hypertension : patients start 5 mg daily . dose increased 2-week intervals 40 mg. ( 2.1 )",
    "warningsAndPrecautions": "nebivolol available tablets oral containing nebivolol hydrochloride equivalent 5 10 mg nebivolol . nebivolol tablets uncoated round-shaped , beveled edge , biconvex , unscored , mottled , differentiated color debossed “ nl ” one side number mg ( 5 10 ) side . nebivolol tablets supplied following strengths package configurations : nebivolol tablets tablet strength package configuration ndc # tablet color 5 mg unit dose packages 30 ( 3 x 10 ) ndc 60687-641-21 beige 10 mg unit dose packages 30 ( 3 x 10 ) ndc 60687-652-21 pinkish-purple store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . protection : blister torn broken .",
    "adverseReactions": "nebivolol contraindicated following conditions : severe bradycardia heart block greater first degree patients cardiogenic shock decompensated cardiac failure sick sinus syndrome ( unless permanent pacemaker place ) patients severe hepatic impairment ( child-pugh greater b ) patients hypersensitive component product .",
    "indications_original": "Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1)",
    "contraindications_original": "Can be taken with and without food. Individualize to the needs of the patient and monitor during up-titration. (2) Hypertension: Most patients start at 5 mg once daily. Dose can be increased at 2-week intervals up to 40 mg. (2.1)",
    "warningsAndPrecautions_original": "Nebivolol is available as tablets for oral administration containing nebivolol hydrochloride equivalent to 5 and 10 mg of nebivolol.\n                  Nebivolol tablets are uncoated round-shaped, beveled edge, biconvex, unscored, mottled, differentiated by color and are debossed with “ \n  NL” on one side and the number of mg (5 or 10) on the other side. Nebivolol tablets are supplied in the following strengths and package configurations:\n \n                  \n                     \n                        \n                        \n                        \n                        \n                     \n                     \n                        \n                           \n                              \n                                 Nebivolol Tablets\n                              \n                           \n                        \n                        \n                           \n                              \n                                 Tablet Strength\n                              \n                           \n                           \n                              \n                                 Package Configuration\n                              \n                           \n                           \n                              \n                                 NDC #\n                              \n                           \n                           \n                              \n                                 Tablet Color\n                              \n                           \n                        \n                        \n                           \n                              5 mg\n                           \n                           \n                              Unit dose packages of 30 (3 x 10)\n                           \n                           \n                              NDC 60687-641-21\n                           \n                           \n                              Beige\n                           \n                        \n                        \n                           \n                              10 mg\n                           \n                           \n                              Unit dose packages of 30 (3 x 10)\n                           \n                           \n                              NDC 60687-652-21\n                           \n                           \n                              Pinkish-Purple\n                           \n                        \n                     \n                  \n                  \n                     Store at 20° to 25°C (68° to 77°F) \n   [see USP for Controlled Room Temperature].\n                     \n                  \n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.",
    "adverseReactions_original": "Nebivolol is contraindicated in the following conditions:\n                  \n                     Severe bradycardia\n                     Heart block greater than first degree\n                     Patients with cardiogenic shock\n                     Decompensated cardiac failure\n                     Sick sinus syndrome (unless a permanent pacemaker is in place)\n                     Patients with severe hepatic impairment (Child-Pugh greater than B)\n                     Patients who are hypersensitive to any component of this product."
}